Comparison · Pregnancy Smart
NIPT vs NT scan: what each screening test shows
How do the options compare?
Options are stacked on five dimensions relevant to pregnancy use: mainstream OB guidance, pregnancy-specific evidence, dosing predictability, onset, and side-effect and interaction profile.
| Option | Studied pregnancy dose | Guideline support | Notes |
|---|---|---|---|
| NIPT or cell-free DNA screening | Maternal blood draw, commonly from about 10 weeks once placental DNA fraction is sufficient. | ACOG describes cfDNA as the most sensitive and specific screen for common fetal aneuploidies, but a positive or no-result screen needs counseling and appropriate follow-up. | Screens selected chromosome conditions. It does not image fetal structure, can produce false results or no result, and does not replace CVS, amniocentesis, or the anatomy ultrasound. |
| Nuchal translucency ultrasound | Time-limited ultrasound measurement, usually between 11 and 14 weeks. | SMFM does not recommend ultrasound solely for NT measurement after a negative cfDNA screen, but ultrasound remains important when performed for broader first-trimester assessment or when an abnormality is seen. | Assesses a physical marker and may reveal early structural findings. An enlarged NT can lead to genetics counseling, detailed imaging, and discussion of diagnostic testing. |
| Second-trimester anatomy ultrasound | Ideally 18 through 22 weeks, regardless of the earlier chromosome-screening choice. | ACOG recommends offering this ultrasound to all patients because fetal structural findings can occur with or without aneuploidy. | This is not a substitute for NIPT or NT-based chromosome risk screening, and a normal early screen does not remove the need to assess anatomy. |
| CVS or amniocentesis | Procedure timing depends on gestational age and specialist counseling. | These are diagnostic options offered when a patient wants greater certainty or when screening or ultrasound raises concern. | Unlike NIPT and NT, diagnostic sampling can directly test fetal or placental cells. The scope, procedure risks, and possibility of placental mosaicism differ by test. |
- ACOG calls cell-free DNA the most sensitive and specific screening option for common fetal aneuploidies, while emphasizing false-positive and false-negative results and that screening is not equivalent to diagnostic testing. It recommends one screening approach rather than simultaneous independent screens. 1
- MedlinePlus explains that NIPT analyzes maternal blood containing placental cell-free DNA, mainly to estimate risk for trisomies 21, 18, and 13 plus selected sex-chromosome differences. A positive result still needs a diagnostic test for confirmation. 2
- A nuchal translucency scan measures fluid at the back of the fetal neck by ultrasound, usually between 11 and 14 weeks. Increased thickness changes risk for chromosome conditions and congenital heart disease but does not confirm that a condition is present. 3
- SMFM does not recommend an 11-to-14-week ultrasound solely for NT measurement after a negative cell-free DNA result. It still recommends offering chromosome microarray testing when ultrasound identifies a structural abnormality. 4
- A national Dutch cohort included 1,901 pregnancies with NT at or above the 95th percentile. Genetic and structural findings extended beyond conditions targeted by standard cfDNA, but the selected high-NT referral population cannot estimate yield among pregnancies with a normal NT. 5
Which option makes sense?
Options in this comparison can differ substantially in suitability. Please consult your healthcare provider to interpret the evidence, limitations, and cautions before choosing an option or changing your plan.
Disclosure: Pregnancy Smart makes pregnancy supplements, though not in this category. This comparison is a plain description of the pregnancy evidence, not a sales page.
Frequently asked questions
Is NIPT more accurate than an NT scan for Down syndrome?
Yes, cell-free DNA is the more sensitive and specific screen for common aneuploidies, including trisomy 21. An NT scan measures an ultrasound marker and can add structural information, but neither result alone confirms or excludes Down syndrome.
Do I still need an NT scan if NIPT is low risk?
SMFM does not recommend an 11-to-14-week ultrasound solely to measure NT after a negative cell-free DNA result. A clinician may still offer a first-trimester ultrasound for dating, number of fetuses, viability, or anatomy based on local practice and individual circumstances.
Can an NT scan find something NIPT misses?
Yes. Ultrasound can show increased neck fluid and some early structural findings, while standard NIPT targets selected chromosome conditions. A high-NT referral cohort contained structural, single-gene, and chromosome findings beyond standard cfDNA scope, although that cohort does not represent normal-NT pregnancies.
Can NIPT replace the 20-week anatomy scan?
No. NIPT estimates risk for selected chromosome conditions and does not image organs or body structure. ACOG recommends offering a structural ultrasound to all patients, ideally between 18 and 22 weeks, regardless of screening choice.
When are NIPT and NT performed?
NIPT is commonly performed from about 10 weeks, when the placental cell-free DNA fraction is usually high enough. NT measurement is usually performed from 11 through 14 weeks and becomes unreliable outside the accepted fetal-size and timing window.
Does a high-risk NIPT result confirm a chromosome condition?
No. NIPT is a screening blood test and can be falsely positive. A high-risk result should lead to genetics counseling, detailed ultrasound, and an offer of CVS or amniocentesis before irreversible pregnancy decisions are made.
Does an enlarged NT confirm a chromosome condition?
No. An enlarged NT changes risk but is not a chromosome result. It can occur with chromosome differences, heart or other structural findings, single-gene conditions, or an otherwise typical outcome. Genetics counseling and diagnostic and imaging options should be discussed.
Should I do both NIPT and first-trimester serum screening?
ACOG advises using one prenatal chromosome-screening approach rather than running multiple independent screening tests at the same time. Ultrasound assessment is a separate source of structural information. The clinician can explain whether an NT measurement is part of a chosen combined-screen pathway.
What does a no-result NIPT mean for an NT scan?
A no-result NIPT is not a low-risk result. Low placental DNA fraction, early timing, sample issues, maternal factors, or fetal factors can contribute. Current guidance calls for counseling, comprehensive ultrasound, and an offer of diagnostic testing rather than relying on NT alone.
Related in the library
Is it safe?
How many weeks pregnant for the NIPT blood test?
Is it safe?
Nuchal translucency scan: timing and the cutoff week
Symptoms
NIPT low fetal fraction no result
Symptoms
Positive NIPT result
Comparisons
Genetic screening test timeline by trimester
Symptoms
High maternal serum AFP pregnancy screen
Symptoms
Vanishing twin syndrome
References
ACOG · https://www.acog.org/advocacy/policy-priorities/non-invasive-prenatal-testing/current-acog-guidance
What is noninvasive prenatal testing (NIPT) and what disorders can it screen for?
MedlinePlus Genetics · https://medlineplus.gov/genetics/understanding/testing/nipt/
MedlinePlus · https://medlineplus.gov/ency/article/007561.htm
The role of ultrasound in women who undergo cell-free DNA screening
Society for Maternal-Fetal Medicine · https://pubmed.ncbi.nlm.nih.gov/28108156/
PubMed · https://pubmed.ncbi.nlm.nih.gov/31697852/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.